Mustang Bio, Inc.
MBIO
MBIO: Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs in cell and gene therapy into potential cures for hematologic cancers, solid tumors and rare genetic diseases. Its pipeline is currently focused on the core areas of gene therapies for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies and CAR T therapies for solid tumors.
moreShow MBIO Financials
Recent trades of MBIO by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by MBIO's directors and management
Government lobbying spending instances
New patents grants
Federal grants, loans, and purchases
Followers on MBIO's company Twitter account
Number of mentions of MBIO in WallStreetBets Daily Discussion
Recent insights relating to MBIO
Recent picks made for MBIO stock on CNBC
ETFs with the largest estimated holdings in MBIO
Flights by private jets registered to MBIO